XML 132 R93.htm IDEA: XBRL DOCUMENT v3.21.1
Share-based payments - Summary of Employee Share Options (Detail)
12 Months Ended
Dec. 17, 2020
$ / shares
Sep. 14, 2020
shares
$ / shares
Jul. 01, 2020
$ / shares
Jun. 30, 2020
shares
$ / shares
Dec. 31, 2020
shares
$ / shares
Dec. 31, 2019
shares
$ / shares
Dec. 31, 2018
shares
$ / shares
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Weighted average exercise price, Outstanding at January 1,         $ 17.45 $ 16.65 $ 16.65
SARs forfeited           16.81 16.65
Weighted average exercise price, Outstanding at December 31,           $ 17.45 $ 16.65
Number of share options, outstanding at January 1, | shares         103,469 74,401 31,880
SARs forfeited | shares           2,936 1,443
Number of share options, outstanding at December 31, | shares           103,469 74,401
Weighted average remaining contract life (years)           8 years 6 months 21 days 9 years 1 month 13 days
Weighted average fair value of options granted     $ 13.79        
Granted On December 2020 [Member]              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
SARs granted           $ 23.82  
SARs granted | shares           5,447  
Share Appreciation Rights [Member]              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Weighted average exercise price, Outstanding at January 1,         $ 1.12 $ 1.12 $ 1.12
SARs forfeited           1.12 1.12
Weighted average exercise price, Outstanding at December 31,           1.12 1.12
SARs vested           $ 1.12 $ 1.12
Number of share options, outstanding at January 1, | shares         43,455 43,675 43,978
SARs forfeited | shares           220 303
Number of share options, outstanding at December 31, | shares           43,455 43,675
SARs vested | shares           117 169
Performance Based Options [Member]              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
SARs forfeited         $ 10.00    
Weighted average exercise price, Outstanding at December 31,         $ 10.00    
SARs forfeited | shares         255,000    
Number of share options, outstanding at December 31, | shares         3,644,000    
Weighted average remaining contract life (years)         9 years 7 months 6 days    
Performance Based Options [Member] | Granted On June 2020 [Member]              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
SARs granted         $ 10.00    
SARs granted | shares       3,644,000 3,644,000    
Weighted average fair value of options granted       $ 11.10 $ 11.10    
Performance Based Options [Member] | Granted On September 2020 [Member]              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
SARs granted         $ 10.00    
SARs granted | shares   255,000     255,000    
Weighted average fair value of options granted   $ 6.41     $ 6.41    
Additional Grants Under 2020 Plan [Member]              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
SARs forfeited         10.00    
Weighted average exercise price, Outstanding at December 31,         $ 9.87    
SARs granted | shares         1,963,566    
SARs forfeited | shares         53,384    
Number of share options, outstanding at December 31, | shares         1,910,182    
Weighted average remaining contract life (years)         9 years 8 months 19 days    
Additional Grants Under 2020 Plan [Member] | Granted On June 2020 [Member]              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
SARs granted         $ 10.00    
SARs granted | shares         1,087,417    
Weighted average fair value of options granted       $ 11.29 $ 11.29    
Additional Grants Under 2020 Plan [Member] | Granted On September 2020 [Member]              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
SARs granted         $ 9.72    
SARs granted | shares         74,000    
Weighted average fair value of options granted   $ 9.25     $ 9.25    
Additional Grants Under 2020 Plan [Member] | Granted On December 2020 [Member]              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
SARs granted         $ 9.70    
SARs granted | shares         802,149    
Weighted average fair value of options granted $ 6.73       $ 6.73    
Converted Options [Member]              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
SARs forfeited         1.08    
Weighted average exercise price, Outstanding at December 31,         2.58    
SARs vested         $ 2.45    
SARs forfeited | shares         37,540    
Number of share options, outstanding at December 31, | shares         594,844    
SARs vested | shares         53,856    
Weighted average remaining contract life (years)         7 years 3 days    
Weighted average fair value of options granted         $ 4.83    
Converted Options [Member] | Granted On June 2020 [Member]              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
SARs granted         $ 2.49    
SARs granted | shares         632,384    
Matching Stock Options [Member]              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
SARs forfeited         $ 10.00    
Weighted average exercise price, Outstanding at December 31,         $ 10.00    
SARs forfeited | shares         8,262    
Number of share options, outstanding at December 31, | shares         1,422,556    
Weighted average remaining contract life (years)         9 years 6 months    
Matching Stock Options [Member] | Granted On June 2020 [Member]              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
SARs granted         $ 10.00    
SARs granted | shares         1,430,818    
Weighted average fair value of options granted         $ 10.59